Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Scleroderma, Diffuse; Scleroderma, Systemic | Phase 1 | ClinicalTrials |
| Neoplasms | Phase 1 | ClinicalTrials |
| Polycythemia; Polycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential; Thrombocytosis | Phase 1 | ClinicalTrials |
CONTENTS